|
About NNF |
| The National Neuroscience Facility was formed
by a stakeholder consortium comprising Neurosciences Victoria Ltd, the Howard
Florey Institute of Experimental Medicine and Physiology, the National Muscular
Dystrophy Research Centre, the Mental Health Research Institute and the
Genomic Disorders Research Centre.
The NNF is governed by Neurosciences Australia Ltd (NSA) - a not-for-profit public company limited by guarantee. NSA is now a growing national enterprise, wholly owned by its members, which include: |
|
| Neurosciences Victoria Ltd | |
| South Australian Neuroscience Institute | |
| University of Tasmania | |
| Western Australian Neuroscience Consortium | |
| Hunter Neurosciences | |
The Aims of the NNF are: |
|
| To provide better access to cutting edge neuroscience technologies and expertise for Australian researchers | |
| To increase R & D effort and effectiveness in the field of neuroscience | |
| To attract overseas researchers and firms into Australia | |
| To form significant clusters of neuroscience R & D activity | |
Objectives |
|
| Create economic and social value by facilitating the commercialisation of neuroscience intellectual property through a vertically and horizontally integrated set of infrastructure, technologies and expertise and through increased national collaborations | |
| Become a globally competitive entity and build recognition as a preferred location for discovery research and clinical product development by leading pharmaceutical companies | |
| Provide national resources for data storage. | |
| Create facilities for scientific training and a national capability for research development and commercialisation through local start-up companies. | |
| Develop and maintain major international and domestic commercial alliances. | |
| Expand existing services and infrastructure into co-located, neuroscience-specific facilities. | |